Legal

Clovis CEO Patrick Mahaffy settles up on SEC charges of lying about the roci data — and it won’t cost much

Legal, Pricing

California insurance commissioner files suit against AbbVie, claims widespread kickback scheme to promote its blockbuster Humira

People

GSK poaches new drug development chief Chris Corsico from Boehringer, dividing R&D into two groups
More news caret

calendar Protocols

Quick hits from around the biopharma web

Sep 18

AstraZeneca touts extended safety and efficacy data on Fasenra; Vanessa King takes the helm at Virion

Sep 17

Argenx buoyed by PhII trial results; Boehringer touts a big batch of real-world COPD data

Sep 14

Hua Medicine reaps $110.5M, adjusting expectations for Hong Kong IPO

Sep 13

Galapagos raises $300M on the back of first PhIII filgotinib success; Incyte pushes into PhIII with topical Jakafi

More Protocols caret

Dollar Premium

Genentech team does some cutting-edge work on a new class of antibiotics — here's why that's important

The high-roller club in biopharma: Who’s paying top-dollar for upfronts? And who are the busiest players at the deal table?

Who are the most productive drug developers in biopharma? Our top-20 list has lots of surprises

Top 10 pipeline blowups, setbacks and snafus in H1 2018

Vant commander Ramaswamy heads back to Nasdaq with a $150M pitch — are investors ready to forgive Axovant?

12 top China VCs you need to know who are making a transpacific splash (Part 2)

twitter Marco

Hot BioTwitter bot - last updated ago

arrow-thick Most Viral

AbbVie accused of paying kickbacks, using a stealthy network to promote Humira

STAT a day

Promising study results thrusts Viking Therapeutics into race for lucrative fatty liver disease treatment - STAT

STAT a day

Harvard Professor's Attack On Pharma's Clinical Trials Is Absurd

Forbes a day

Can patient advocates help make Akcea the next Sarepta? - STAT

STAT a day

A snapshot of upbeat PhII NASH data - from a very small trial - triggers a frenzy for Viking's stock

ENDPOINTS NEWS John Carroll a day

After back-to-back trial flops, Realm slashes its staff, halts research work and ponders a fire sale

ENDPOINTS NEWS John Carroll a day

Scientists Close To Developing Life-Saving Vaccine That They Can Rub In Faces Of Their Doubters

the-onion The Onion a day

GSK poaches new drug development chief Chris Corsico from Boehringer, dividing R&D into two groups

ENDPOINTS NEWS John Carroll a day

What men say when I tell them I focus on funding female founders

Financial Times a day

Xconomy: Viking Liver Drug Shows Promise for NASH, Shares Soar on Study Data

Xconomy Ben Fidler a day

timer Latest

IN

California insurance regulator sues AbbVie alleging Humira kickbacks

Financial Times

California sues AbbVie over kickbacks to boost Humira sales

IN

Clovis Oncology, execs to pay $20 million to settle SEC charges

New York Times

Why Your DNA Is Still Uncharted Territory

HealthNewsReview.org

What did journalists overlook about the Apple Watch 'heart monitor' feature?

the-onion

Scientists Close To Developing Life-Saving Vaccine That They Can Rub In Faces Of Their Doubters

STAT

AbbVie accused of paying kickbacks, using a stealthy network to promote Humira

Beacon Medical Interchange

Hyper-Progressive Disease on Immunotherapy in NSCLC - BeaconMedIC

Xconomy

Xconomy: Viking Liver Drug Shows Promise for NASH, Shares Soar on Study Data

ENDPOINTS NEWS

GSK poaches new drug development chief Chris Corsico from Boehringer, dividing R&D into two groups

fire Hot This Week

1

WSJ

Nearly 600 Russia-Linked Accounts Tweeted About the Health Law

2

STAT

AbbVie accused of paying kickbacks, using a stealthy network to promote Humira

3

STAT

Biotech unicorn Moderna prepares for sector's biggest-ever IPO - STAT

4

BusinessWire

U.S. Department of Justice Grants Clearance to Cigna's Acquisition of Express Scripts

5

STAT

Global Blood's FDA filing plan for a sickle cell drug is riskier than you think - STAT

6

STAT

Promising study results thrusts Viking Therapeutics into race for lucrative fatty liver disease treatment - STAT

7

Forbes

Harvard Professor's Attack On Pharma's Clinical Trials Is Absurd

8

STAT

H. Gilbert Welch resigns from Dartmouth over 'idea plagiarism' dispute - STAT

9

The Kansas City Star

Gift lets KU Hospital expand blood cancer treatment, CAR-T | The Kansas City Star

10

FDA

Antimicrobial Resistance Information from FDA

Contact Endpoints News

You can also contact John Carroll, Editor at john@endpointsnews.com

← Go back
Thank you for staying with us. It's great to have you on board!
Aww, shucks. Perhaps you can tell us what we could do to make you interested in subscribing?
← Go back